Gartner Ranks Informatica as the Number One iPaaS Solution

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
47
Gartner Ranks Informatica as the Number One iPaaS Solution Provider Worldwide for Third Consecutive Year

REDWOOD CITY, Calif., April 25, 2017 (GLOBE NEWSWIRE) -- Informatica ® , the world’s No. 1 provider of  data management solutions , today announced that Gartner, Inc., a leading IT research and advisory firm, has, for the third consecutive year, ranked Informatica as the number one global Integration Platform as a Service (iPaaS) solution provider. This ranking is based on 2016 market share revenue identified in Gartner’s report “Market Share: All Software Markets, Worldwide, 2016 [1] ” for Enterprise Integration Platform as a Service (iPaaS) in the Application and Infrastructure Middleware Market.

Last month, the Gartner 2017 Magic Quadrant for Enterprise Integration Platform as a Service (iPaaS) report positioned Informatica as a Leader in the iPaaS industry for the fourth straight year. In fact, in this report, Informatica was positioned highest on the ability to execute axis and farthest on the completeness of vision axis.

In its new iPaaS market share report, Gartner sizes the 2016 global iPaaS market at $688 million, with Informatica accounting for $127 million in iPaaS revenue, or 19 percent of the whole and six percentage points more than the closest competitor. With its iPaaS revenues growing 40 percent year-over-year from $91 million in 2015 and more than doubling from 2014, Informatica is in hypergrowth mode and is the only iPaaS vendor operating at more than $100 million scale.

“We believe 2016 was a watershed year for the global iPaaS market, and for Informatica iPaaS solutions in particular as we further solidified our position as a recognized iPaaS leader for vision, execution and ranked number one for iPaaS market share revenue,” said Ronen Schwartz, senior vice president and general manager, Data Integration, Big Data and Cloud, Informatica. “Informatica customers continue to move aggressively in transitioning integration workloads and data to cloud environments. Informatica currently has more than 5,000 enterprise iPaaS customers, connected to thousands of applications and moving more than 22 billion transactions per day, with 100 percent year-over-year transaction growth rate. As these customers invest in our solutions, we continue to invest aggressively to bring to market the ‘next’ generation of innovative iPaaS and data management solutions that will enhance their journeys to the cloud.”

The Informatica Cloud ®  market leading iPaaS delivers the broadest set of cloud integration/iPaaS capabilities on a single platform across all systems, in the cloud and on-premise. Informatica is a  pioneer in cloud integration  and now more than 1.5 million jobs are processed with Informatica Cloud every day, demonstrating the growth in workloads shifting to the cloud and driving today’s hybrid cloud era. Customers depend on Informatica Cloud to underpin such key use cases as data integration, application integration, process integration, data quality, master data management (MDM), data security, B2B integration, data preparation and more across multiple types of environments, all powered by Informatica’s iPaaS platform.

Tweet this: News: @Gartner_inc ranks @Informatica no. 1 #iPaaS solution provider worldwide in 2016, 3rd year in a row http://infa.media/pr170425a   

Gartner positioned Informatica as a Leader in all six recent Magic Quadrants in Informatica’s market:

About the Magic Quadrant Gartner does not endorse any vendor, product or service depicted in its research publications, and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner research publications consist of the opinions of Gartner’s research organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose.

About Informatica Informatica is 100 percent focused on data because the world runs on data. Organizations need business solutions around data for the cloud, big data, real-time and streaming. Informatica is the world’s No. 1 provider of data management solutions, in the cloud, on-premise or in a hybrid environment. More than 7,000 organizations around the world turn to Informatica for data solutions that power their businesses. For more information, call +1 650-385-5000 (1-800-653-3871 in the U.S.), or visit www.informatica.com . Connect with Informatica at https://linkedin.com/company/informatica , https://twitter.com/Informatica and https://facebook.com/InformaticaLLC .

###

Note: Informatica and Informatica Cloud are registered trademarks of Informatica in the United States and in jurisdictions throughout the world. All other company and product names may be trade names or trademarks of their respective owners.


[1] Source: Gartner, Inc., Market Share: All Software Markets, Worldwide, 2016, Matthew Cheung, et al, 14 April 2017

Maureen O’Connell Informatica +1 650 385 4022 - office +1 408 679 0648 - mobile Shira Frantzich Informatica +1 650 385 5674 - office

Scroll down for more posts ▼

Top 10 Most Recent News Articles

KINGRVER Boosts RV Comfort with New Water Heater Lineup

Updated Category News Views 9

An Upgrade for the Open Road In the land of RV living, comfort is king—or in this case, KINGRVER. Dropping affordable upgrades for water heaters into the world of RVs, KINGRVER's CT6 lineup is like a warm hug on a chilly campsite morning. Whether you've pulled up to a wooded retreat or parked under the vast desert sky, having dependable hot water shouldn't be a gamble....

Continue Reading
JOYEE N01 Debuts Globally with First 2,000 Deliveries

Updated Category News Views 123

JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 52

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
Lilly's Obesity Breakthroughs: A Step Beyond the Scale

Updated Category News Views 422

Pushing the Boundaries of Obesity Treatment Alright, let's cut through the noise and get to what really matters here. Eli Lilly is taking on obesity treatment like it's Clash of the Titans at this year's ObesityWeek 2026 in Washington, D.C. Forget just dropping pounds—Lilly wants to reshape how we think about obesity entirely. They're not just leaning into the scale,...

Continue Reading
Uber Data Breach: Class Action Investigation Begins

Updated Category News Views 175

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 104

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading
CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 0

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 432

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading
Shenzhen's Vision Unveiled: APEC 2026 Promo Debut

Updated Category News Views 287

Shenzhen's Spotlight Moment at APEC 2026 When Shenzhen announced its promotional video for the 2026 APEC Economic Leaders' Meeting, it wasn't just about standard tourism glitz. This was a show of force, a bold step onto the main stage of global politics and economics. The video's launch wasn’t merely an audio-visual delight—it staked a claim in shaping the future...

Continue Reading
YSTUDIO's Pens: A Nod to the Power of Writing

Updated Category News Views 557

Slow Down, Write On: A New Era for Stationery In a world where sentiments zip around with a swipe, here we find YSTUDIO tapping into something analog and profound. Their latest offerings—a 'Brand Day Gift Box' and the 'Inner Universe' pen series—are more than just high-end stationery. They’re an invitation to reconnect with the written word, a gesture to slow our...

Continue Reading

Top 5 Most Recently Viewed Articles

NKGen Biotech to Present Innovative Research at Global Congress

Updated Category News Views 157

NKGen Biotech's Exciting Announcement on Upcoming Presentation NKGen Biotech Inc. (NASDAQ: NKGN), a pioneering clinical-stage biotechnology firm dedicated to developing cutting-edge autologous and allogeneic natural killer cell therapies, has recently shared some thrilling news regarding their participation in an international event. Highlighting Neurodegenerative...

Continue Reading
Celebrating Case Managers: A Call to Action for 2025

Updated Category News Views 522

Recognizing the Contribution of Case Managers in 2025 Case managers have proven time and again to be essential contributors to the health and human services spectrum. In 2025, the two prominent organizations in the case management field—the American Case Management Association (ACMA) and the Commission for Case Manager Certification (CCMC)—have once again partnered to...

Continue Reading
Faruqi & Faruqi Investigates Ford Investor Claims

Updated Category News Views 92

Back in 2024, Faruqi & Faruqi took aim at Ford Motor Company (NYSE: F), investigating claims from investors who’d racked up losses over $100,000. They were diving deep into the financial mess at Ford—a colossal vehicle manufacturer that found itself knee-deep in allegations of breaching federal securities laws. The chatter was all about how quality assurance failures...

Continue Reading
Entourage Health Announces Going-Private Arrangement Plan

Updated Category News Views 236

Entourage Health Corp. Takes a Bold Step Toward Going-Private Entourage Health Corp. (TSX-V: ENTG) (OTCQX: ETRGF) has officially entered into a significant arrangement agreement with 1001007762 Ontario Inc. and 2437653 Ontario Inc. This strategic move, a statutory plan under the Business Corporations Act (Ontario), sees the Purchaser agreeing to acquire all common shares...

Continue Reading
A&W Revenue Royalties Income Fund Q3 2024 Results Review

Updated Category News Views 183

A&W Revenue Royalties Income Fund Q3 2024 Financial Overview TRADING SYMBOL: TSX: AW.UN A&W Revenue Royalties Income Fund has reported encouraging results for the third quarter ending this year. The quarterly performance reflects steady royalty income growth and strategic developments that promise an exciting future. Royalty Income Performance In the third quarter of...

Continue Reading